"bionaive" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "bio-",
        "3": "naive"
      },
      "expansion": "bio- + naive",
      "name": "af"
    }
  ],
  "etymology_text": "From bio- + naive.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "bionaive (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "antonyms": [
        {
          "word": "bioexperienced"
        }
      ],
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with bio-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Medicine",
          "orig": "en:Medicine",
          "parents": [
            "Biology",
            "Healthcare",
            "Sciences",
            "Health",
            "All topics",
            "Body",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2022 August 30, Ricardo Ruiz-Villaverde, Lourdes Rodriguez Fernandez-Freire, Pilar Font-Ugalde, Manuel Galan-Gutierrez, “Tildrakizumab: Efficacy, Safety and Survival in Mid-Term (52 Weeks) in Three Tertiary Hospitals in Andalucia (Spain)”, in Journal of Clinical Medicine, volume 11, number 17, →DOI, page 5:",
          "text": "In the bivariate analysis carried out by subgroups, we did not find statistically significant differences (p < 0.05) between bionaïve or bioexperienced patients, patients with BMI < 30 or BMI > 30 in relation to the efficacy variables (PASI and BSA) and analyzed PROs (VAS pruritus and DLQI).",
          "type": "quote"
        }
      ],
      "glosses": [
        "Not having received biological treatment in the past."
      ],
      "id": "en-bionaive-en-adj-~CtYscBC",
      "links": [
        [
          "medicine",
          "medicine"
        ],
        [
          "biological",
          "biological"
        ],
        [
          "treatment",
          "treatment"
        ]
      ],
      "raw_glosses": [
        "(medicine) Not having received biological treatment in the past."
      ],
      "synonyms": [
        {
          "word": "bio-naive"
        },
        {
          "word": "bionaïve"
        },
        {
          "word": "bio-naïve"
        }
      ],
      "tags": [
        "not-comparable"
      ],
      "topics": [
        "medicine",
        "sciences"
      ]
    }
  ],
  "word": "bionaive"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "bio-",
        "3": "naive"
      },
      "expansion": "bio- + naive",
      "name": "af"
    }
  ],
  "etymology_text": "From bio- + naive.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "bionaive (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "antonyms": [
        {
          "word": "bioexperienced"
        }
      ],
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with bio-",
        "English terms with quotations",
        "English uncomparable adjectives",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Medicine"
      ],
      "examples": [
        {
          "ref": "2022 August 30, Ricardo Ruiz-Villaverde, Lourdes Rodriguez Fernandez-Freire, Pilar Font-Ugalde, Manuel Galan-Gutierrez, “Tildrakizumab: Efficacy, Safety and Survival in Mid-Term (52 Weeks) in Three Tertiary Hospitals in Andalucia (Spain)”, in Journal of Clinical Medicine, volume 11, number 17, →DOI, page 5:",
          "text": "In the bivariate analysis carried out by subgroups, we did not find statistically significant differences (p < 0.05) between bionaïve or bioexperienced patients, patients with BMI < 30 or BMI > 30 in relation to the efficacy variables (PASI and BSA) and analyzed PROs (VAS pruritus and DLQI).",
          "type": "quote"
        }
      ],
      "glosses": [
        "Not having received biological treatment in the past."
      ],
      "links": [
        [
          "medicine",
          "medicine"
        ],
        [
          "biological",
          "biological"
        ],
        [
          "treatment",
          "treatment"
        ]
      ],
      "raw_glosses": [
        "(medicine) Not having received biological treatment in the past."
      ],
      "tags": [
        "not-comparable"
      ],
      "topics": [
        "medicine",
        "sciences"
      ]
    }
  ],
  "synonyms": [
    {
      "word": "bio-naive"
    },
    {
      "word": "bionaïve"
    },
    {
      "word": "bio-naïve"
    }
  ],
  "word": "bionaive"
}